Concepedia

Author

Ilenia Migliaccio

Hospital of PratoORCID

Also Known As

I Migliaccio, I. Migliaccio, Ilenia Migliaccio, Migliaccio, Ilenia

169

Publications

3.3K

Citations

30

H-Index

30

Concepts

All Affiliations

Hospital of PratoBaylor College of MedicineUniversity of Naples Federico IIEuropean Institute of OncologyUniversity of Milan
IM

About

Ilenia Migliaccio is an author at Hospital of Prato specializing in medicine, radiation oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

891

2

Cell Biology

7

7

492

3

Engineering

1

1

17

4

Health Sciences

1

1

265

5

Obstetrics

1

1

10

Ilenia Migliaccio

×

34

Publications

2.4K

Citations

24

H-Index

YearCitations

Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase

Tingting Sun, Nicola Aceto, Kristen L. Meerbrey,

Cell

2011

274

Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma

Giuliana Salvatore, Riccardo Giannini, Pinuccia Faviana,

The Journal of Clinical Endocrinology & Metabolism

2004

265

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Bhuvanesh Dave, Ilenia Migliaccio, Maya Gutierrez,

Journal of Clinical Oncology

2010

256

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study

C. Kent Osborne, Patrick Neven, Luc Dirix,

Clinical Cancer Research

2011

181

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer

Luca Malorni, Silvano Piazza, Yari Ciani,

Oncotarget

2016

151

UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas

Pierlorenzo Pallante, Maria Teresa Berlingieri, Giancarlo Troncone,

British Journal of Cancer

2005

132

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

Cristina Guarducci, Martina Bonechi, Matteo Benelli,

npj Breast Cancer

2018

123

Complex Regulation of the Cyclin-Dependent Kinase Inhibitor p27kip1 in Thyroid Cancer Cells by the PI3K/AKT Pathway

Maria Letizia Motti, Daniela Califano, Giancarlo Troncone,

American Journal Of Pathology

2005

95

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Luca Malorni, Giuseppe Curigliano, Alessandro Marco Minisini,

Annals of Oncology

2018

94

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo,

Clinical Cancer Research

2021

91

Page 1